Study on methods and requirements for quality control of recombinant human tumor necrosis factor receptor Fc fusion protein

Yaoxue Xuebao

Volumn 38, Issue 3, 2003, Pages 165-168

  Zhang, Yi ^a   Gao, Kai ^a   Han, Chun Mei ^a   Rao, Chun Ming ^a   Wang, Jun Zhi ^a  

^a NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Biological potency; Quality control; Requirements; rhTNFR Fc

Indexed keywords

HYBRID PROTEIN; IMMUNOGLOBULIN G; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; ARTICLE; BIOSYNTHESIS; BIOTECHNOLOGY; CELL CULTURE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; METHODOLOGY; MOUSE; PEPTIDE MAPPING; PHARMACEUTICS; QUALITY CONTROL; STANDARD;

ANIMALS; BIOTECHNOLOGY; CELL DIVISION; IMMUNOGLOBULIN G; MICE; PEPTIDE MAPPING; QUALITY CONTROL; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; TECHNOLOGY, PHARMACEUTICAL; TUMOR CELLS, CULTURED;

EID: 2142745360     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Firestein GS. VIP: A very important protein in arthritis [J]. Nat Med, 2001,7(5):537-538.
2. Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project [J]. J Clin Epidemiol, 1998,51(11):903-912.
3. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis [J]. Annu Rev Immunol, 1996,14(1):397-440.
4. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death [J]. Cell, 1994,76(6):959-962.
5. Murray KM, Dahl SL. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis [J]. Ann Pharmacother, 1997,31(11):1335-1338.
6. Wang JZ, GaoK, Rao CM. Determination method of rhTNF-α bioassay and mechanism of rhTNF-α on human leukmic HL-60 cells [J]. Chin J Cancer Biother, 1998,6(2):141-144.
7. Rao CM, Zhang Y, Han CM, et al. Peptide mapping analysis of recombinant human interleukin-11 by tryptic digestion [J]. Acta Pharm Sin, 2000,35(5):378-380.
8. Zhang Y, Wang JZ, Guo Y, et al. Physical and chemical characteristics and peptide mapping of recombinant human GM-CSF [J]. Chin J Cancer Biother, 1998,5(2):105-108.
9. Committee of Chinese Biologicals Standarization. National Requirements for Biologicals [M]. Beijing: Chemical Industry Press, 2000.370-375.
10. Zhou HJ. Technical Requirements for Registration of Pharmaceuticab for Human Use - Quality [M]. Beijing: People's Medical Publishing House, 2000.143-149.